Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP63 isoform expression is linked with distinct clinical outcomes in cancer

1 Jan 2020

Abstract excerpt

BACKGROUND: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with clinical outcomes are conflicting. Since TP63 is expressed as multiple isoforms, we hypothesized that these conflicting associations with clinical outcome may be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31927310
DOI: 10.1016/j.ebiom.2019.11.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP63 isoform expression is linked with distinct clinical outcomes in cancerPMID 31927310Read ↗

Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.Semantic proximity Read ↗

A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissuesSemantic proximity Read ↗

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.Semantic proximity Read ↗

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.Semantic proximity Read ↗

Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune SignaturesSemantic proximity Read ↗

Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerSemantic proximity Read ↗

Isoform-specific cofactor recruitment through the intrinsically disordered N-terminus of p63 underlies differential transcriptional activitiesSemantic proximity Read ↗

The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.Semantic proximity Read ↗

Tissue-specific expression of p73 and p63 isoforms in human tissuesSemantic proximity Read ↗

p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.Semantic proximity Read ↗

Distinct interactors define the p63 transcriptional signature in epithelial development or cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.